Robert K Kerlan Jr
Overview
Explore the profile of Robert K Kerlan Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1083
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee A, Lehrman E, Perito E, Kerlan Jr R, Kohi M, Kolli K, et al.
Pediatr Transplant
. 2021 May;
25(6):e14028.
PMID: 33951255
Background: To evaluate the efficacy of percutaneous and endoscopic therapeutic interventions for biliary strictures and leaks following LT in children. Methods: Retrospective analysis of 49 consecutive pediatric liver transplant recipients...
2.
Lokken R, Kerlan Jr R, Chung Y, Chen Y, Mehta N, Yao F, et al.
AJR Am J Roentgenol
. 2021 Mar;
216(5):1283-1290.
PMID: 33703926
The purpose of this study was to identify risk factors for and outcomes of hepatotoxicity after selective chemoembolization of hepatocellular carcinoma. This retrospective study included 182 patients (136 men and...
3.
Drapek L, Kerlan Jr R, Acquisto S
Chin Clin Oncol
. 2020 Mar;
9(1):9.
PMID: 32146819
Hepatobiliary and pancreatic cancers can cause malignant biliary constriction of the bile ducts, a lethal complication that leads to obstruction of the bile ducts, cholangitis, sepsis, and death. Patients may...
4.
Devulapalli K, Fidelman N, Soulen M, Miller M, Johnson M, Addo E, et al.
Radiology
. 2018 May;
288(3):774-781.
PMID: 29737954
Purpose To determine the frequency of hepatobiliary infections after transarterial radioembolization (TARE) with yttrium 90 (Y) in patients with liver malignancy and a history of biliary intervention. Materials and Methods...
5.
Kohi M, Poder L, Thiet M, Kerlan Jr R
J Vasc Interv Radiol
. 2017 Aug;
28(9):1295-1297.
PMID: 28841941
No abstract available.
6.
Fidelman N, Kerlan Jr R, Hawkins R, Pampaloni M, Taylor A, Kohi M, et al.
J Gastrointest Oncol
. 2017 Jan;
7(6):860-874.
PMID: 28078110
Background: This prospective pilot single-institution study was undertaken to document the feasibility, safety, and efficacy of radioembolization of liver-dominant metastatic gastrointestinal cancer using Y glass microspheres. Methods: Between June 2010...
7.
Lokken R, Fidelman N, Kolli K, Kerlan Jr R
J Vasc Interv Radiol
. 2016 Nov;
27(12):1938-1939.
PMID: 27886963
No abstract available.
8.
Lokken R, Fidelman N, Kolli K, Kerlan Jr R
J Vasc Interv Radiol
. 2016 Jul;
27(11):1698-1704.
PMID: 27397617
Purpose: To assess safety and efficacy of doxorubicin drug-eluting embolic (DEE) transarterial chemoembolization of hepatocellular carcinoma (HCC) by extrahepatic collateral arteries. Materials And Methods: Records of 177 patients with HCC...
9.
Rafiei P, Walser E, Duncan J, Rana H, Ross J, Kerlan Jr R, et al.
J Vasc Interv Radiol
. 2016 Apr;
27(5):695-9.
PMID: 27038685
No abstract available.
10.
Taylor A, Kolli K, Kerlan Jr R
Tech Vasc Interv Radiol
. 2016 Mar;
19(1):74-81.
PMID: 26997091
Transjugular intrahepatic portosystemic shunts (TIPS) effectively lower portal pressure and are commonly used to manage selected patients with variceal bleeding. Unfortunately, significant consequences are not infrequently encountered as a result...